Yes, our weight loss program in Los Angeles, California is designed to accommodate a wide range of dietary preferences and restrictions, including vegetarian, vegan, gluten-free, and more
The compound received marketing approval in China in June 2025 under the brand name Xinermei, making it the first domestically approved dual GLP-1/glucagon agonist anywhere in the world
Since I already know this category from both my coaching work and my own experience using Join Josie, I wanted to see what GobyMeds actually looked like before I mentioned it to anyone
How and where do I administer the injection
For non-diabetic patients whose insurance denies coverage entirely, the cash-pay options are the same as for everyone else: NovoCare ($149 to $349/month), LillyDirect ($299 to $449/month), or patient assistance programs if income-eligible
Aggregation potential increases